Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Cell adhesion inhibitors developed by Sumitomo researchers

Oct. 2, 1998

MMP inhibitors from Bayer particularly useful for osteoarthritis and tumor metastasis

Oct. 2, 1998

Peptides that bind to MHC class II proteins in development at Zeneca

Oct. 1, 1998

Selectin inhibitors described by Sanwa Kagaku for inflammatory disorders

Oct. 1, 1998

Piperazines as inhibitors of MMPs and/or TNF-alpha prepared at Fujisawa

Oct. 1, 1998

NPS Pharmaceuticals initiates clinical trials for NPS-1776

Oct. 1, 1998

New arthritis Rx now available in Japan

Sep. 30, 1998

Selectin inhibitors under study at Kanebo

Sep. 28, 1998

TheraTech receives NIH funding for novel approach to rheumatoid arthritis

Sep. 24, 1998

Mitsui Chemicals prepares cell adhesion inhibitors

Sep. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...